Stacy J. Kanter - Net Worth and Insider Trading

Stacy J. Kanter Net Worth

The estimated net worth of Stacy J. Kanter is at least $269,640 dollars as of 2024-04-29. Stacy J. Kanter is the Director of Applied Therapeutics Inc and owns about 63,000 shares of Applied Therapeutics Inc (APLT) stock worth over $269,640. Details can be seen in Stacy J. Kanter's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stacy J. Kanter has not made any transactions after 2023-12-01 and currently still holds the listed stock(s).

Transaction Summary of Stacy J. Kanter

To

Stacy J. Kanter Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stacy J. Kanter owns 2 companies in total, including Applied Therapeutics Inc (APLT) , and Oppenheimer Holdings Inc (OPY) .

Click here to see the complete history of Stacy J. Kanter’s form 4 insider trades.

Insider Ownership Summary of Stacy J. Kanter

Ticker Comapny Transaction Date Type of Owner
APLT Applied Therapeutics Inc 2023-12-01 director
OPY Oppenheimer Holdings Inc 2023-10-25 director

Stacy J. Kanter Latest Holdings Summary

Stacy J. Kanter currently owns a total of 1 stock. Stacy J. Kanter owns 63,000 shares of Applied Therapeutics Inc (APLT) as of December 1, 2023, with a value of $269,640.

Latest Holdings of Stacy J. Kanter

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
APLT Applied Therapeutics Inc 2023-12-01 63,000 4.28 269,640

Holding Weightings of Stacy J. Kanter


Stacy J. Kanter Form 4 Trading Tracker

According to the SEC Form 4 filings, Stacy J. Kanter has made a total of 3 transactions in Applied Therapeutics Inc (APLT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Applied Therapeutics Inc is the acquisition of 30,000 shares on December 1, 2023, which cost Stacy J. Kanter around $65,400.

Insider Trading History of Stacy J. Kanter

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stacy J. Kanter Trading Performance

GuruFocus tracks the stock performance after each of Stacy J. Kanter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stacy J. Kanter is 44.9%. GuruFocus also compares Stacy J. Kanter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stacy J. Kanter within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stacy J. Kanter's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stacy J. Kanter

Average Return

-73.31%

Average return per transaction

Outperforming Transactions

0%

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.88 44.9 -39.17 -73.31 -77.6 -54.21
Relative Return to S&P 500(%) 6.83 43.38 -44.68 -86.75 -86.83 -62.28

Stacy J. Kanter Ownership Network

Ownership Network List of Stacy J. Kanter

No Data

Ownership Network Relation of Stacy J. Kanter


Stacy J. Kanter Owned Company Details

What does Applied Therapeutics Inc do?

Who are the key executives at Applied Therapeutics Inc?

Stacy J. Kanter is the director of Applied Therapeutics Inc. Other key executives at Applied Therapeutics Inc include director & 10 percent owner & President and CEO Shoshana Shendelman , Chief Commercial Officer Adam Hansard , and Chief Medical Officer Riccardo Perfetti .

Applied Therapeutics Inc (APLT) Insider Trades Summary

Over the past 18 months, Stacy J. Kanter made 1 insider transaction in Applied Therapeutics Inc (APLT) with a net purchase of 30,000. Other recent insider transactions involving Applied Therapeutics Inc (APLT) include a net sale of 454,043 shares made by Shoshana Shendelman , a net sale of 129,372 shares made by Riccardo Perfetti , and a net sale of 64,051 shares made by Adam Hansard .

In summary, during the past 3 months, insiders sold 506,975 shares of Applied Therapeutics Inc (APLT) in total and bought 0 shares, with a net sale of 506,975 shares. During the past 18 months, 1,251,193 shares of Applied Therapeutics Inc (APLT) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 1,221,193 shares.

Applied Therapeutics Inc (APLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Applied Therapeutics Inc Insider Transactions

No Available Data

Stacy J. Kanter Mailing Address

Above is the net worth, insider trading, and ownership report for Stacy J. Kanter. You might contact Stacy J. Kanter via mailing address: C/o Applied Therapeutics, Inc., 340 Madison Avenue, 19th Floor, New York Ny 10173.

Discussions on Stacy J. Kanter

No discussions yet.